Kardigan fashions $254M Series B to spin late-stage cardio assets through clinic fiercebiotech.com 1 points by randycupertino 8 hours ago
randycupertino 8 hours ago Kardigan founders are same team who successfully sold MyoKardia to BMS for $13.1 billion or $225 per share.
Kardigan founders are same team who successfully sold MyoKardia to BMS for $13.1 billion or $225 per share.